Placebo Controlled, Randomized Safety and Efficacy Study of RC-1291 in Cancer Anorexia/Cachexia.
Status:
Completed
Trial end date:
2006-10-01
Target enrollment:
Participant gender:
Summary
Anorexia and cachexia are devastating complications in late-stage cancer patients and is
strongly associated with mortality in these patients. Activation of Ghrelin receptors have
been demonstrated to stimulate appetite. RC-1291 HCl, by virtue of its ghrelin like activity
and Growth Hormone releasing effects may have a dual role in the reversal of cancer induced
anorexia and cachexia. This placebo controlled study will evaluate the safety and efficacy of
RC-1291 HCl in cancer patients with anorexia and cachexia.